How to buy Veru stock (VERU)

Veru is a biotechnology business based in the US. Veru shares (VERU) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.71 – a decrease of 2.9% over the previous week. Veru employs 189 staff and has a trailing 12-month revenue of around $14.1 million.

Our top picks for where to buy Veru stock

Buy Veru stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Veru stock price (NASDAQ: VERU)

Use our graph to track the performance of VERU stocks over time.

Veru shares at a glance

• Key figures

Information last updated 2024-12-12.

Latest market close	$0.71
52-week range	$0.36 - $1.92
50-day moving average more info button	$0.76
200-day moving average more info button	$0.90
Wall St. target price	$3.40
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-0.30

Is it a good time to buy Veru stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Veru price performance over time

Historical closes compared with the close of $0.7227 from 2024-12-13

1 week (2024-12-10)	0.35%
1 month (2024-11-18)	22.45%
3 months (2024-09-17)	-7.71%
6 months (2024-06-17)	-13.13%

1 year (2023-12-15)	-4.91%
2 years (2022-12-16)	-85.52%
3 years (2021-12-17)	6.34
5 years (2019-12-17)	2.87

Veru financials

Revenue TTM	$14.1 million
Gross profit TTM	$30.6 million
Return on assets TTM	-64.36%
Return on equity TTM	-126.72%
Profit margin	-265.42%
Book value	$0.26
Market Capitalization more info button	$107.5 million

TTM: trailing 12 months

Veru share dividends

We're not expecting Veru to pay a dividend over the next 12 months.

Veru share price volatility

Over the last 12 months, Veru's shares have ranged in value from as little as $0.36 up to $1.92. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Veru's is -0.463. This would suggest that Veru's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Veru has bucked the trend.

Veru overview

Veru Inc. , a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). Its marketed products comprise FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. The company's development program includes enobosarm, a selective androgen receptor modulator for treatment of augment fat loss and to prevent muscle loss in sarcopenic obese and overweight elderly patients; Enobosarm, a selective androgen receptor modulator for the treatment of AR+ ER+ HER2- metastatic breast cancer; and sabizabulin, a microtubule disruptor for the treatment of hospitalized patients with viral lung infection on oxygen support who are at high risk for viral induced ARDS and death. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. Veru Inc.

Frequently asked questions

What percentage of Veru is owned by insiders or institutions?
Currently 14.104% of Veru shares are held by insiders and 42.036% by institutions. How many people work for Veru?
Latest data suggests 189 work at Veru. When does the fiscal year end for Veru?
Veru's fiscal year ends in September. Where is Veru based?
Veru's address is: 2916 North Miami Avenue, Miami, FL, United States, 33127 What is Veru's ISIN number?
Veru's international securities identification number is: US92536C1036 What is Veru's CUSIP number?
Veru's Committee on Uniform Securities Identification Procedures number is: 976817106